Spark Newswire Spark Newswire
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
News by Category
  • After-Hours Center
  • Analyst Color
  • Analyst Ratings
  • Asia
  • Asset Sales
  • Binary Options
  • Biotech
  • Bonds
  • Broad U.S. Equity ETFs
  • Buybacks
  • Cannabis
  • Commodities
  • Contracts
  • Crowdsourcing
  • Cryptocurrency
  • Currency ETFs
  • Dividends
  • Downgrades
  • Earnings
  • Earnings Beats
  • Earnings Misses
  • Econ #s
  • Economics
  • Education
  • Emerging Market ETFs
  • Emerging Markets
  • Entertainment
  • Entrepreneurship
  • Equities
  • ESG
  • ETFs
  • Eurozone
  • Events
  • Exclusives
  • FDA
  • Federal Reserve
  • Financial Advisors
  • Financing
  • Fintech
  • Forex
  • Futures
  • Gaming
  • General
  • Global
  • Government
  • Guidance
  • Health Care
  • Hedge Funds
  • Hot
  • Initiation
  • Insider Trades
  • Insurance
  • Interview
  • Intraday Update
  • IPOs
  • Large Cap
  • Latin America
  • Legal
  • Long Ideas
  • M&A
  • Macro Economic Events
  • Macro Notification
  • Management
  • Market Summary
  • Market-Moving Exclusives
  • Markets
  • Media
  • Mid Cap
  • Mining
  • Movers
  • Movers & Shakers
  • Mutual Funds
  • New ETFs
  • News
  • Offerings
  • Opinion
  • Options
  • Penny Stocks
  • Personal Finance
  • Politics
  • Pre-Market Outlook
  • Press Releases
  • Previews
  • Price Target
  • Psychedelics
  • Psychology
  • Real Estate
  • Regulations
  • REIT
  • Reiteration
  • Restaurants
  • Retail Sales
  • Reviews
  • Rumors
  • SEC
  • Sector ETFs
  • Short Ideas
  • Short Sellers
  • Signals
  • Small Business
  • Small Cap
  • Small Cap Analysis
  • Small-Cap
  • Social Media
  • SPACE
  • Specialty ETFs
  • Sports
  • Sports Betting
  • Startups
  • Stock Split
  • Success Stories
  • Tech
  • Technicals
  • Termination
  • Top Stories
  • Topics
  • Trading Ideas
  • Travel
  • Treasuries
  • Uncategorized
  • Upgrades
Spark Newswire Spark Newswire
Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
Spark Newswire Spark Newswire
Filter By Ticker
Search By Date To
Today | Yesterday | This week
Browsing Category

Guidance

Group By Ticker
Sort By
Newest | Oldest
Read More
2 minute read
  • Guidance
  • News

Zuora Sees Q1 EPS $0.00-$0.01 Vs $0.00 Est.; Q1 Revenue $101M-$103M Vs $102.75M Est.; FY24 EPS $0.07-$0.11 Vs $0.08 Est.; FY24 Revenue $428M-$440M Vs $432.01M Est.

By Happy Mohamed
March 1, 5:29 PM
Financial Outlook: As of March 1, 2023, we are providing guidance for the first quarter and full fiscal year 2024 based on current market conditions and expectations. We emphasize that

ZUO

Read More
2 minute read
  • Guidance
  • News

Jazz Pharmaceuticals Sees FY23 EPS $16.90-$17.85 Vs $18 Est.; FY23 Revenue $3.675B-$3.875B Vs $3.76B Est.

By Happy Mohamed
March 1, 5:23 PM
2023 Financial Guidance Jazz Pharmaceuticals' full year 2023 financial guidance is as follows: (In

JAZZ

Read More
2 minute read
  • Guidance
  • News

Box Sees Q1 EPS $0.26-$0.27 Vs $0.3 Est.; Q1 Revenue $248M-$250M Vs $260.24M Est.; Sees FY23 EPS $1.42-$1.48 Vs $1.47 Est.; FY23 Revenue $$1.05B-$1.06B Vs $1.1B Est.

By Happy Mohamed
March 1, 5:17 PM
Outlook The following guidance includes the impact of any expected foreign exchange headwinds, assuming present foreign currency exchange rates. Q1 FY24 Guidance Revenue is expected to be in the

BOX

Read More
1 minute read
  • Earnings
  • Guidance
  • Movers
  • News
  • Penny Stocks
  • Small Cap
  • Trading Ideas

Why Invitae Corporation Shares Are Falling Today

By Sean Torres
March 1, 3:31 PM
Invitae Corporation (NYSE: NVTA) shares are trading lower this Wednesday after the company reported fourth-quarter financial results and provided guidance for full-year 2023. The company also announced that it has signed exchange and financing agreements with a fund managed by Deerfield Management C

NVTA

Read More
1 minute read
  • Earnings
  • Guidance
  • Movers
  • News
  • Trading Ideas

Why Payoneer Global Stock Is Trading Higher Today

By Sean Torres
March 1, 2:57 PM
Payoneer Global (NASDAQ: PAYO) shares are trading higher after the company reported better-than-expected fourth-quarter EPS and issued full-year 2023 guidance above estimates.

PAYO

Read More
2 minute read
  • Earnings
  • Guidance
  • News

What’s Going On With Luminar Technologies Stock Today?

By Sean Torres
March 1, 2:46 PM
Luminar Technologies (NASDAQ: LAZR) shares are trading lower this Wednesday after the company reported worse-than-expected Q4 earnings.

LAZR

Read More
1 minute read
  • Earnings
  • General
  • Guidance
  • News
  • Small Cap

Abercrombie & Fitch Q4 Highlights: 3% Sales Growth, Bottom-Line Miss, Lower Inventories On Production Delays In Vietnam & More

By Shivani Kumaresan
March 1, 1:34 PM
Abercrombie & Fitch Co (NYSE:ANF) reported fourth-quarter FY22 sales growth of 3% year-on-year to $1.199 billion, beating the consensus of $1.18…

ANF

Read More
1 minute read
  • Guidance
  • News

MeridianLink Sees Q1 Revenue Of $72M-$75M; FY23 Revenue Of $304M-$310M

By Happy Mohamed
March 1, 11:56 AM
Business Outlook Based on information as of today, March 1, 2023, the Company issues first quarter financial guidance and initiates full year 2023 financial guidance as follows: First

MLNK

Read More
1 minute read
  • Earnings
  • General
  • Guidance
  • Movers
  • News
  • Penny Stocks

LL Flooring Drops After Q4 Earnings Miss; Dodges FY23 Financial Guidance Citing Macro Uncertainty

By Shivani Kumaresan
March 1, 11:38 AM
LL Flooring Holdings, Inc. (NYSE:LL) reported a fourth-quarter sales decline of 7.5% year-on-year to $263.87 million, missing the consensus of $267.60…

LL

Read More
1 minute read
  • Earnings
  • Guidance
  • News
  • Top Stories

ODP Q4 Recap: Posts 3% Topline Growth Amid Industry Headwinds, Remains Cautious Over FY23

By Anusuya Lahiri
March 1, 10:28 AM
 

ODP

Posts pagination

Previous 1 … 476 477 478 … 637 Next
Free Newsletter subscribe

Stock Market Ideas & Analysis

Stay up-to-date with the same information professionals use.
Spark Newswire Spark Newswire
  • Newswire
  • Registration
  • Log In
  • Settings
  • Privacy Policy
  • Terms of Service
© 2021 Spark Newswire
All Rights Reserved.

All news is property of their respective owners. Terms of Service